Cas:26603-23-6 N,N-Bis(octylphenyl)amine manufacturer & supplier

Chemical Name:N,N-Bis(octylphenyl)amine

CAS.NO:26603-23-6

Synonyms:VANOX 12;VANLUBE(R) 81;Benzenamine,ar-octyl-N-(octylphenyl);Einecs 247-839-0;P,P’-DIOCTYLDIPHENYLAMINE;bis(octylphenyl)amine;VANLUBE-81;Octyl-N-(octylphenyl)aniline;AGERITE STALITE S

Molecular Formula:C₂₈H₄₃N

Molecular Weight:393.64800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:509.4ºC at 760mmHg

Density:0.939g/cm3

Index of Refraction:1.534

PSA:12.03000

Exact Mass:393.34000

LogP:9.30920

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like VANOX 12 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,AGERITE STALITE S physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,VANLUBE-81 Use and application,VANOX 12 technical grade,usp/ep/jp grade.

Related News: The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. N,N-Bis(octylphenyl)amine manufacturer The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body. N,N-Bis(octylphenyl)amine supplier Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies. N,N-Bis(octylphenyl)amine vendor Any US citizen who has been in the Hubei province in the last 14 days will be subject to up to 14 days of mandatory quarantine upon return to the United States. N,N-Bis(octylphenyl)amine factory The purpose of APIs according to the FDA is to cause ��pharmacological activity or other direct effects in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the human body.